FindTrial
Sign In

A clinical trial to study the effect of redefining active phase of labour from 4cm to 5cm of cervical dilatation (WHO 2018 guideline ) with minimal intervening the process of labour continuing at its natural pace without compromising feet-maternal outcome.

Analysing the expectant management of redefined active phase of labour (WHO 2018) in nulliparous women: A randomized control trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031429
Enrollment
136
Registered
2021-02-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O80- Encounter for full-term uncomplicated delivery

Interventions

Intervention1: NIL: STUDY OF LABOUR AT ITS NATURAL PACE WITHOUT/WITH MINIMAL INTERVENTION. Intervention2: ARM, oxytocin, episiotomy, forceps, vacuum, cesarean delivery.: If there will be non-reassurin

Sponsors

Dr Anshika Tandon
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Non-high risk nulliparous women of age between 18 to 35 years. Height equal to or >145 cm. Singleton live intrauterine pregnancy. Vertex with occipito-anterior position No medical or surgical complications, obstetrical complication and pelvic pathology. Women with the average gynaecoid pelvis, spontaneous onset of labour pains & given consent for the study. The patient will be considered once they enter the active phase as per group allocation.

Exclusion criteria

Exclusion criteria: Multipara Malpresentation Multifetal pregnancy Women with premature rupture of membranes (if any) of more than 24 hours duration. The patient who was previously allocated groups on admission but required intervention in the latent phase. Any obstetrical complications like GDM, pre-eclampsia, contracted pelvis, cholestatic jaundice etc. Medical disorders like cardiac, renal, hepatic disease, hypertension, DM, thyroid disorder. Pelvic pathologies like ovarian cyst, fibroid, any previous uterine surgery, etc. Presence of congenital fetal malformation like anencephaly, hydrocephalus, etc. Small for gestation age (birth weight 90 percentile). Precipitate labour.

Design outcomes

Primary

MeasureTime frame
Duration of labour: i.e. active phase to delivery Need for intervention: Indications for intervention: Mode of delivery:Timepoint: 48 HOURS i.e 2 days—

Secondary

MeasureTime frame
Neonatal outcome: Apgar at 1&5min: Resuscitative measures used: NICU admission & diagnosis: Maternal outcome: Intrapartum complications: Postpartum complications:Timepoint: 5 days—

Countries

India

Contacts

Public ContactDr Anshika Tandon

Bhagat Phool Singh Govt. Medical College For Women

dr.rmahendru@gmail.com9416086483

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026